Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro

被引：49

作者：

Gruber, A

Speth, C

Lukasser-Vogl, E

Zangerle, R

Borg-von Zepelin, M

Dierich, MP

Würzner, R

机构：

[1] Univ Innsbruck, Ludwig Boltzman Inst AIDS Forsch, A-6020 Innsbruck, Austria

[2] Univ Innsbruck, Inst Dermatol & Venereol, A-6020 Innsbruck, Austria

[3] Univ Gottingen, Inst Hyg, D-3400 Gottingen, Germany

来源：

IMMUNOPHARMACOLOGY | 1999年 / 41卷 / 03期

基金：

奥地利科学基金会;

关键词：

Candida albicans; Indinavir; HIV-1;

D O I：

10.1016/S0162-3109(99)00035-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The putative virulence factor secreted aspartyl proteinase (SAP) of Candida albicans and the human immunodeficiency virus type 1 (HIV-1) protease both belong to the aspartyl proteinase family. The present study demonstrates that the HIV-1 protease inhibitor Indinavir is a weak but specific inhibitor of SAP. In addition, Indinavir reduces the amount of cell bound as well as released SAP antigen from C. albicans. Furthermore, viability and growth of C. albicans are markedly reduced by Indinavir, These findings indicate that HIV-1 protease inhibitors may possess antifungal activity and we speculate that in vivo SAP inhibition may add to the resolution of mucosal candidiasis in HIV-1 infected subjects. (C) 1999 Elsevier Science B.V. All rights reserved.

引用

页码：227 / 234

页数：8

共 31 条

[1]

AbadZapatero C, 1996, PROTEIN SCI, V5, P640

[2] The SWISS-PROT protein sequence data bank and its supplement TrEMBL [J].